News | Apr 21
After Regulatory Setback, 80 Framingham Biotech Workers Are Losing Their Jobs
After Regulatory Setback, 80 Framingham Biotech Workers Are Losing Their Jobs
Replimune Group failed to win regulatory approval for a new drug treating skin cancer, and the result is a total of more than 220 job cuts.